26.12.2012 Views

IARC MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC ...

IARC MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC ...

IARC MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Table 10 (contd)<br />

Reference<br />

(country)<br />

Coggon et al.<br />

(1987)<br />

(United<br />

Kingdom)<br />

Bond et al.<br />

(1992)<br />

(USA)<br />

Kolstad et al.<br />

(1993, 1994,<br />

1995)<br />

(Denmark)<br />

Type of plant; study period;<br />

number of subjects; minimal<br />

period employed; follow-up<br />

Production of glass-reinforced<br />

plastics (8 facilities);<br />

1947–84; 7949 subjects; no<br />

minimal employment;<br />

variable, 61.9–99.7%<br />

Dow Chemical workers in<br />

development or production of<br />

styrene-based products;<br />

1940–86; 2904 men; 1 year;<br />

96.7%<br />

Production of glass fibrereinforced<br />

plastics and other<br />

plastics (552 facilities); 1970–<br />

89; 53 720 men and 10 798<br />

women; no minimal<br />

employment; 98.2%<br />

No of<br />

deaths/<br />

cancer<br />

deaths<br />

Results<br />

No. SMR/<br />

SIR<br />

95% CI Site<br />

Comments (previous evaluation)<br />

693/181 6 [0.40] [0.15–0.88] L&H, mortality One of six deaths from L&H with high exposure<br />

to styrene. Extended follow-up of this cohort<br />

included by Kogevinas et al. (1994a,b) (<strong>IARC</strong>,<br />

1994a)<br />

687/162 15<br />

2<br />

5<br />

56<br />

6<br />

4281/2285<br />

incident<br />

cases<br />

28<br />

174<br />

66<br />

112<br />

42<br />

90<br />

16<br />

0.86<br />

[0.39]<br />

0.49<br />

0.81<br />

0.95<br />

1.4<br />

[1.1]<br />

[1.1]<br />

1.2<br />

1.2<br />

0.87<br />

1.2<br />

0.48–1.4<br />

0.04–1.4<br />

0.16–1.1<br />

0.61–1.0<br />

0.35–2.1<br />

0.95–2.1<br />

[0.93–1.3]<br />

[0.86–1.4]<br />

0.98–1.4<br />

0.88–1.7<br />

0.70–1.1<br />

0.68–1.9<br />

Large intestine<br />

Rectum<br />

Pancreas<br />

Lung<br />

Brain/other nervous<br />

system<br />

L&H<br />

L&H, men/women<br />

Leukaemia, men/women<br />

L&H, men a<br />

Leukaemia, men a<br />

Breast, women<br />

Brain and nervous<br />

system, women<br />

A mortality study, updating of Ott et al. (1980).<br />

From among L&H cancers, elevated incidences<br />

of multiple myeloma and Hodgkin disease<br />

(<strong>IARC</strong>, 1994a)<br />

Significantly higher incidence of leukaemia<br />

(SIR, 1.6) among men at ≥ 10 years since first<br />

exposure; incidence of leukaemia higher among<br />

short-term male workers with estimated higher<br />

exposure to styrene; part of this cohort included<br />

by Kogevinas et al. (1994a,b) (<strong>IARC</strong>, 1994a)<br />

STYRENE 465

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!